Tricida Competitors and Similar CompaniesClear all

Tricida's competitors and similar companies include Array BioPharma, Biofrontera, Avid Bioservices and BTG.
Tricida
Tricida
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Biofrontera
Biofrontera
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
Avid Bioservices
Avid Bioservices
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
BTG
BTG
BTG is an international specialist healthcare company.
Founding Date
Founding Date
2013
Founding Date
1998
Founding Date
2012
Founding Date
1981
Founding Date
1948
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Boulder, US HQ
Chicago, US
Detroit, US
Houston, US
Miami, US
New York, US
Phoenix, US
Locations
Leverkusen, DE HQ
Locations
Tustin, US HQ
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Yokne'am Illit, IL
see more
Employees
Employees
11914% increase
Employees
1101% increase
Employees
91
Employees
21114% increase
Employees
6515% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.1 m
Valuation ($)
649.4 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
€32.2m (FY, 2023)
Revenue (est.)
$139.9m (FY, 2024)
Revenue (est.)
£731.3m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$59.4m (FY, 2018)
Cost of goods
€5.5m (FY, 2023)
Cost of goods
$132.6m (FY, 2024)
Cost of goods
£221m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$114.4m (FY, 2018)
Gross profit
€27.4m (FY, 2023)
Gross profit
$7.3m (FY, 2024)
Gross profit
£510.3m (FY, 2019)
Net income
Net income
($176.6m) (FY, 2021)
Net income
($147.7m) (FY, 2018)
Net income
(€369k) (FY, 2023)
Net income
($140.8m) (FY, 2024)
Net income
£88.3m (FY, 2019)
For sources of this data, please see the company profile

View Company Profiles

Array BioPharma
HQ
Boulder, US

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Biofrontera
HQ
Leverkusen, DE
Employees
91

Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.

View company
Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.

View company
BTG
HQ
London, GB

BTG is an international specialist healthcare company.

View company